ARDX
NASDAQ · Biotechnology
Ardelyx Inc
$5.50
+0.15 (+2.80%)
Open$5.46
Previous Close$5.35
Day High$5.52
Day Low$5.45
52W High$8.40
52W Low$3.21
Volume—
Avg Volume5.40M
Market Cap1.50B
P/E Ratio—
EPS$-0.26
SectorBiotechnology
Analyst Ratings
Strong Buy
18 analysts
Price Target
+757.1% upside
Current
$5.50
$5.50
Target
$47.14
$47.14
$33.22
$47.14 avg
$55.45
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 409.09M | 206.19M | 556.78M |
| Net Income | -61,875,094 | -28,068,339 | -22,621,785 |
| Profit Margin | -15.1% | -14.4% | -4.1% |
| EBITDA | -37,643,103 | -18,024,671 | -31,484,723 |
| Free Cash Flow | — | — | -21,445,059 |
| Rev Growth | +98.4% | +98.4% | +16.2% |
| Debt/Equity | 1.21 | 1.21 | 0.37 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |